In vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum
- PMID: 20566767
- PMCID: PMC2934947
- DOI: 10.1128/AAC.00793-10
In vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum
Abstract
This study evaluated the in vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum isolated from HIV-positive patients. The drugs were tested by microdilution testing in accordance with the CLSI guidelines. All of the strains were inhibited by sulfamethoxazole-trimethoprim, with MIC ranges of 0.039 (sulfamethoxazole)/0.0078 (trimethoprim) mg/ml to 0.625/0.125 mg/ml for mycelial forms and 0.0025/0.0005 to 0.02/0.004 mg/ml for yeast-like forms. However, in vivo studies are necessary to evaluate the significance of these results.
References
-
- Ajayi, B. G., B. Osuntokun, O. Olurin, O. O. Kale, and T. A. Junaida. 1986. Orbital histoplasmosis due to Histoplasma capsulatum var. duboisii: successful treatment with septrin. J. Trop. Med. Hyg. 89:179-187. - PubMed
-
- Baddley, J. W., I. R. Sankara, J. M. Rodriquez, P. G. Pappas, and W. J. Many, Jr. 2008. Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy. Diagn. Microbiol. Infect. Dis. 62:151-156. - PubMed
-
- Daher, E. F., G. B. Silva, Jr., F. A. Barros, C. F. Takeda, R. M. Mota, M. T. Ferreira, S. A. Oliveira, J. C. Martins, S. M. Araújo, and O. A. Gutiérrez-Adrianzén. 2007. Clinical and laboratory features of disseminated histoplasmosis in HIV patients from Brazil. Trop. Med. Int. Health 12:1108-1115. - PubMed
-
- Egere, J. U., H. C. Gugnani, A. N. Okoro, and A. V. Suseelan. 1978. African histoplasmosis in Eastern Nigeria: report of two culturally proven cases treated with septrin and amphotericin B. J. Trop. Med. Hyg. 81:225-229. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
